In neurodegeneration models, AGK2, a sirtuin inhibitor with higher selectivity for SIRT2 (IC50 for SIRT1 >50 μM and SIRT2 23.5 μM, respectively) showed protection from alpha-synuclein toxicity in Parkinson’s disease model [6]. This evidence concerns the gene SIRT1 and Parkinson disease.